Necitumumab is a monoclonal antibody that is used in the treatment of certain types of cancer, specifically non-small cell lung cancer. It works by targeting and blocking a protein called epidermal growth factor receptor (EGFR), which is found on the surface of cancer cells. By inhibiting this protein, necitumumab helps to slow down the growth and spread of cancer cells.

This drug is typically used in combination with other chemotherapy medications to improve the effectiveness of treatment. It is administered through intravenous infusion in a medical setting, usually once a week. Your healthcare provider will determine the appropriate dosage and schedule for your specific condition.

As with any medication, necitumumab may cause side effects. Common side effects include skin rash, diarrhea, fatigue, and low magnesium levels. It is important to discuss any concerns or symptoms with your healthcare provider to ensure proper management of side effects.

It is also important to inform your healthcare provider about any other medications or supplements you are taking, as they may interact with necitumumab. Additionally, it is important to follow all instructions provided by your healthcare provider and attend all scheduled appointments to monitor your response to treatment.

Overall, necitumumab can be an important part of a comprehensive treatment plan for non-small cell lung cancer. Your healthcare provider will work with you to determine if this medication is appropriate for your specific situation and provide guidance on how to best manage any side effects that may occur.